Corporate finance
Search documents
Taina Kyllönen appointed as eQ’s Chief People and Communications Officer and member of the Management Team
Globenewswire· 2025-11-19 07:00
Core Viewpoint - eQ Plc has appointed Taina Kyllönen as the new Chief People and Communications Officer, effective by February 1, 2026, to enhance its management team and support the company's growth strategy [2][3]. Group 1: Appointment Details - Taina Kyllönen will report directly to CEO Jouko Pölönen and brings over 20 years of experience in communications, investor relations, and marketing from her previous roles at the University of Helsinki and other companies [2][3]. - Kyllönen's expertise includes corporate culture development and brand building, which aligns with eQ's entrepreneurial and skilled team [3]. Group 2: Company Overview - eQ Plc focuses on asset management and corporate finance, managing approximately EUR 13.7 billion in assets [5]. - The company offers a variety of asset management services, including private equity funds and real estate asset management, catering to both institutions and private individuals [5].
X @Bitcoin Magazine
Bitcoin Magazine· 2025-10-28 20:29
RT Bitcoin For Corporations (@BitcoinForCorps)📺 The Bitcoin For Corporations ShowEpisode 18 now live — hosted by @BitcoinPierrePierre Rochard hosts Israel Salmen (@IsraelSalmen), Chairman of Méliuz ($CASH3), and Mason Foard (@MasonFoard), Director of Bitcoin Strategy, to discuss how the Brazilian e-commerce giant reinvented itself into the nation’s first #Bitcoin treasury company.They explore how #Bitcoin treasuries, high inflation, and Brazil’s regulatory landscape are reshaping corporate finance in emergi ...
cbdMD, Inc. Announces Closing of $1.7 Million Series B Preferred Private Placement
Newsfile· 2025-10-01 20:15
Core Points - cbdMD, Inc. has completed a Series B Preferred Private Placement, raising $1.7 million from institutional investors [1][2] - The company plans to use the net proceeds of $1.5 million for working capital and general corporate purposes [1][2] - The Series B Convertible Preferred Stock issued has a 10% annual dividend and is convertible into common stock at an initial price of $1.00 per share [2] Financial Position - The CEO stated that the company ended the fiscal year with over $2.2 million in cash, indicating a strengthened balance sheet [2] - The financing is aimed at bolstering shareholder equity and supporting ongoing initiatives for distribution expansion and profitability [2] Company Overview - cbdMD, Inc. is a wellness company offering a range of hemp-derived cannabinoid products, including CBD, CBG, and CBN [4] - The company emphasizes quality, innovation, and transparency, distributing products online and through retail partners across the U.S. [4]
Nordicus Partners Corporation Appoints Three New Members to Its Board of Directors
Globenewswire· 2025-08-07 13:50
Core Insights - Henrik Keller has resigned from the Board of Directors of Nordicus Partners Corporation, leading to an expansion of the Board from three to five members with the appointments of Torben Jensen, Kim T. Mücke, and Andrew J. Ritter [1][2] Group 1: Board Changes - The Board of Directors has increased from three to five members following the resignation of Henrik Keller [1] - Torben Jensen, a major shareholder, will assist in funding Nordicus and its subsidiaries [2] - Kim T. Mücke will serve as chairman of the Audit Committee, bringing extensive experience from Deloitte [2][4] - Andrew J. Ritter, an experienced CEO in the pharma space, will aid in corporate finance and strategic relationships [2][5] Group 2: New Board Members' Backgrounds - Torben Jensen has over 35 years of experience in finance and has previously held CEO and Chairman positions in listed companies [3] - Kim T. Mücke is a state-authorized public accountant with a background in financial reporting and risk management, previously a partner at Deloitte [4] - Andrew J. Ritter has a strong background in the biotech and MedTech sectors, having served as CEO in multiple companies [5] Group 3: Company Overview - Nordicus Partners Corporation is a publicly traded business accelerator and holding company focused on Nordic life sciences companies [6] - The company has successfully acquired 100% of two Danish preclinical-stage biotech companies, Orocidin A/S and Bio-Convert A/S, in 2024 [6]